These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31940631)
1. Report of Dialysis-Induced Hypophosphatemia Leading to Reversible Encephalopathy Prevented by Adding Phosphorus to the Dialysate. Koganti D; Sam R Blood Purif; 2020; 49(4):496-501. PubMed ID: 31940631 [TBL] [Abstract][Full Text] [Related]
2. Preventing/treating hypophosphatemia by adding phosphate to the dialysate. Sam R; Tang HL; Kjellstrand CM; Ing TS Int J Artif Organs; 2015 Dec; 38(12):671-2. PubMed ID: 26689145 [No Abstract] [Full Text] [Related]
3. Use of a phosphorus-enriched hemodialysate to prevent hypophosphatemia in a patient with renal failure-related pericarditis. Emelife-Obi C; Chow MT; Qamar-Rohail H; Leehey DJ; Gandhi VC; Ing TS Clin Nephrol; 1998 Aug; 50(2):131-3. PubMed ID: 9725787 [TBL] [Abstract][Full Text] [Related]
4. Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: treatment with phosphorus-enriched hemodialysis. Chow MT; Lin HJ; Mitra EA; Singh S; Lee E; Leehey DJ; Ing TS Artif Organs; 1998 Oct; 22(10):905-7. PubMed ID: 9790091 [TBL] [Abstract][Full Text] [Related]
5. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling. Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493 [TBL] [Abstract][Full Text] [Related]
7. Treatment of severe lithium poisoning and dialysis-induced hypophosphatemia with phosphorus-enriched hemodialysis: a case report. Chebrolu SB; Yang HK; Hariman A; Tzamaloukas AH; Kjellstrand CM; Ing TS Chin Med J (Engl); 2005 Aug; 118(16):1405-8. PubMed ID: 16157041 [No Abstract] [Full Text] [Related]
8. Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate. Gatchalian RA; Popli A; Ejaz AA; Leehey DJ; Kjellstrand CM; Ing TS Am J Kidney Dis; 2000 Dec; 36(6):1262-6. PubMed ID: 11096051 [TBL] [Abstract][Full Text] [Related]
9. Management of hypophosphatemia in nocturnal hemodialysis with phosphate-containing enema: a technical study. Su WS; Lekas P; Carlisle EJ; Cowin R; Bellamy J; Margetts PJ; Brimble KS; Clase CM; Gangji AS Hemodial Int; 2011 Apr; 15(2):219-25. PubMed ID: 21395970 [TBL] [Abstract][Full Text] [Related]
10. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related]
11. Use of a phosphorus-enriched dialysate in a hypercatabolic renal failure patient receiving intensive hemodialysis therapy. Zabaneh RI; Bhatt DM; Yu AW; Tiwari P; Lai CI; Leehey DJ; Ing TS Nephron; 1996; 72(4):696-8. PubMed ID: 8730447 [TBL] [Abstract][Full Text] [Related]